These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Tumor markers for endocrine neoplasms]. Okamoto T Gan To Kagaku Ryoho; 2001 Apr; 28(4):561-5. PubMed ID: 11329795 [TBL] [Abstract][Full Text] [Related]
43. Thyroglobulin: a specific serum marker for the management of thyroid carcinoma. Whitley RJ; Ain KB Clin Lab Med; 2004 Mar; 24(1):29-47. PubMed ID: 15157556 [TBL] [Abstract][Full Text] [Related]
46. Contemporary imaging for thyroid cancer. Wang TS; Cheng DW; Udelsman R Surg Oncol Clin N Am; 2007 Apr; 16(2):431-45. PubMed ID: 17560521 [TBL] [Abstract][Full Text] [Related]
47. Lessons from a review of thyroglobulin assays in the management of thyroid cancer. Wong J; Lu Z; Doery J; Fuller P Intern Med J; 2008 Jun; 38(6):441-4. PubMed ID: 18613899 [TBL] [Abstract][Full Text] [Related]
51. [Thyroid carcinoma]. Tamaki H Gan To Kagaku Ryoho; 2005 Apr; 32(4):561-5. PubMed ID: 15853229 [TBL] [Abstract][Full Text] [Related]
52. Circulating thyroid cancer markers. Gupta M; Chia SY Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):383-8. PubMed ID: 17940468 [TBL] [Abstract][Full Text] [Related]
53. [Role of markers in the diagnosis and follow-up of thyroid carcinomas]. Carmignani F; Piscopello L; Sammartini C Chir Ital; 1994; 46(4):42-5. PubMed ID: 7882442 [TBL] [Abstract][Full Text] [Related]